美农生物 reported revenue of ¥0.33B for the period ended 2026-06-30, +38.7% year on year. Net income was ¥0.02B, a 5.5% net margin on a 29.5% gross margin. The largest revenue line is 功能性饲料添加剂 at 54% of the total. Free cash flow for the period was ¥-0.02B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.33B | +38.7% |
| Gross profit | ¥0.10B | — |
| Operating income | ¥0.02B | — |
| Net income | ¥0.02B | -23.2% |
| Gross margin | 29.5% | Net margin 5.5% |
| Revenue Q/Q | +6.0% | — |
| Segment | Revenue | Share |
|---|---|---|
| 功能性饲料添加剂 | ¥0.18B | 54.3% |
| 营养性饲料添加剂 | ¥0.08B | 23.8% |
| 酶解蛋白饲料原料 | ¥0.05B | 16.5% |
| 浓缩饲料 | ¥0.01B | 3.4% |
| 其他(补充) | ¥0.01B | 2.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.23B | 70.5% |
| R&D | ¥0.01B | 4.0% |
| SG&A | ¥0.05B | 15.0% |
| Tax & other | ¥0.00B | 0.5% |
| Item | Amount |
|---|---|
| Total assets | ¥0.81B |
| Total liabilities | ¥0.08B |
| Shareholders' equity | ¥0.73B |
| Equity / assets | 90.0% |
| Operating cash flow | ¥-0.01B |
| Capital expenditure | ¥0.02B |
| Free cash flow | ¥-0.02B |
| Cash conversion (OCF / net income) | -38% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
华塑科技 ・ 德石股份 ・ 三维天地 ・ 翔楼新材 ・ 唯万密封 ・ 国能日新 ・ 宏德股份 ・ 优宁维 ・ 建研设计 ・ 通灵股份 ・ 零点有数 ・ 锡南科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies